Developer docs
API playgroundTry for free, no card

Search company profiles

Ascribe Bioscience

Full company profile

uuid0002hdh

Namestring
Ascribe Bioscience
Legal namestring
Ascribe Bioscience Inc.
Websiteurl
ascribebio.com
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Ascribe Bioscience is a private agricultural biotechnology company founded in 2017 and headquartered in Ithaca, New York. It was spun out of the Boyce Thompson Institute at Cornell University and develops crop protection products based on ascarosides — small signaling molecules naturally produced by soil microbiome organisms that prime plants' innate immune systems against fungal, bacterial, and viral pathogens.

The company's flagship product, Phytalix®, is a natural small-molecule biofungicide positioned as a new category of crop protection. Unlike conventional fungicides that act through toxicity, Phytalix strengthens plant defenses and is non-toxic, biodegradable, non-GMO, and bee-friendly. The product is effective at milligram-per-acre concentrations, can be applied as a foliar spray, seed treatment, or tank mix with other inputs, and is claimed to enable growers to cut synthetic fungicide use by 50% or more while maintaining yields. The platform is backed by a decade of research and more than 500 field trials worldwide.

Ascribe operates a B2B, channel-driven go-to-market rather than selling direct to growers. Distribution is anchored by Loveland Products (a Nutrien division) for U.S. row crops, Corteva for seed-treatment applications, and Syngenta under an exclusive arrangement for Southeast Asia (with planned 2029 launch). Initial regulatory approval is being pursued in Brazil, followed by the U.S. and other markets. The company serves large-scale commodity growers (wheat, soy, potatoes, row crops) as the primary segment, with specialty crop producers as a secondary segment. As of late 2025 it has raised approximately $14.5M in disclosed funding across seed and Series A rounds from investors including Corteva Catalyst, Acre Venture Partners, Syngenta Group Ventures, and ICIG Ventures.

Short descriptiontext

Ascribe Bioscience is a Cornell-spinout agricultural biotech that develops Phytalix®, a natural small-molecule biofungicide based on soil-microbiome signaling molecules (ascarosides) that prime plant immunity, sold to commodity and specialty growers via channel partners Nutrien/Loveland, Corteva, and Syngenta.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersIthaca, United States
HQ citystring
Ithaca
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biological crop protection, natural biofungicides, plant disease management, agricultural biotechnology, soil microbiome solutions
Industry4 codes
PRIMARYAFABAEAL
Biological Seed Treatments & Inoculants (within Biologicals)
Agriculture & Food Production/Agricultural Inputs & Agrochemicals/Biologicals & Biopesticides (Microbials, Botanicals, Beneficial Insects)
SECONDARYAFABAAAC
Fungicides
Agriculture & Food Production/Agricultural Inputs & Agrochemicals/Crop Protection Chemicals (Herbicides, Insecticides, Fungicides)
SECONDARYAFABAKAJ
Soil Health Activators & Biostimulants (Humates, Amino Acids, Seaweed Extracts)
Agriculture & Food Production/Agricultural Inputs & Agrochemicals/Organic & Regenerative Inputs (OMRI Inputs, Compost, Natural Pest Control)
SECONDARYAFABAFAJ
Seed Inoculants & Biological Seed Enhancers (Rhizobia, Mycorrhizae, PGPR)
Agriculture & Food Production/Agricultural Inputs & Agrochemicals/Seed & Planting Inputs (Seeds, Seed Treatments, Inoculants)
NAICS code2 codes
  • Pesticide and Other Agricultural Chemical Manufacturing32532
  • Pesticide, Fertilizer, and Other Agricultural Chemical Manufacturing3253
SIC code1 code
  • Agricultural Chemicals2870
Product category
Crop Protection Biofungicides
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Phytalix Biofungicide Sales
TypeOne Time License
Description

Revenue generated from sale of Phytalix, a natural crop protection product. The product is sold to farmers and agricultural producers for crop disease control and plant health benefits. Applied as foliar spray or seed treatment.

ascribebio.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1Phytalix
Description

Natural small-molecule biofungicide that provides broad-spectrum protection against fungal, bacterial, and viral diseases. Non-toxic, biodegradable, and can be applied as seed treatment or foliar spray.

ascribebio.com
Core offering1 text field

Ascribe Bioscience develops and commercializes Phytalix®, a natural small-molecule biofungicide that uses ascaroside signaling molecules from the soil microbiome to prime plants' innate defense systems against fungal, bacterial, and viral pathogens. The product is sold to farmers and agricultural producers as a foliar spray, seed treatment, or tank mix, and is positioned to reduce synthetic fungicide use by 50% or more while maintaining yields. Distribution is delivered through agricultural input channel partners (Loveland Products/Nutrien, Syngenta) and direct enterprise sales across the U.S., Brazil, and Southeast Asia.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Reduces synthetic fungicide applications by 50% or more while maintaining yields
+2 more records
Product overview1 text field

Ascribe Bioscience develops natural crop protection solutions based on small molecules (ascarosides) from the soil microbiome. The company's portfolio centers on Phytalix®, a single flagship natural small-molecule biofungicide that can be applied as foliar spray or seed treatment. Phytalix® strengthens plants' innate immune systems rather than relying on toxic effects to kill pathogens, offering broad-spectrum protection against fungal, bacterial, and viral diseases while being environmentally friendly, non-toxic, and bee-friendly. The product enables growers to reduce synthetic fungicide applications by 50% or more while maintaining yields.

Product and service3 records
1Phytalix® Biofungicide
CategoryBiofungicide / Crop Protection
Description

A natural small-molecule biofungicide that primes plants' innate defense systems against fungal, bacterial, and viral diseases. Applied as foliar spray, seed treatment, or tank mix; non-toxic, biodegradable, non-GMO, and bee-friendly. Designed for farmers and agricultural producers seeking to reduce synthetic fungicide use by 50% or more while maintaining yields.

2Phytalix® Seed Treatment Application
CategorySeed Treatment / Crop Protection
Description

A seed treatment variant/extension of the Phytalix® biofungicide platform developed in collaboration with Corteva, allowing growers to apply Phytalix® directly to seeds to protect against soil- and seedling-stage pathogens, broadening use cases beyond foliar application.

3Phytalix® for Asian Markets (Southeast Asia)
CategoryBiofungicide / Crop Protection (Regional)
Description

Geographic/market variant of the Phytalix® biofungicide being commercialized through Syngenta with exclusive rights in Southeast Asia for Asian farmers, targeting regional fungal and other crop pathogens with the same natural small-molecule mode of action.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierFlagshipTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-06-04
Description

Strategic partnership to develop and commercialize PHYTALIX® for Asian farmers. Syngenta receives exclusive rights for Southeast Asia with plans for market launch in 2029, following extensive validation and trials.

2Corteva
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2026-03-11
Description

Collaboration announced to advance seed treatment use for Phytalix® biofungicide, expanding the product's application method beyond foliar sprays.

simplywall.st
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Collaboration with Loveland Products, a division of Nutrien, to launch Phytalix-based solutions for U.S. row crops. The partnership has expanded over time, indicating ongoing commercial collaboration.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

AgBiome is a U.S.-based agricultural biologicals company that discovers and develops microbial biopesticides and biostimulants for crop protection, directly comparable to Ascribe's natural, microbiome-derived biofungicide strategy and row-crop focus.

TypeEmerging player
Description

BioConsortia is a U.S. ag biotech company that uses microbial consortia to develop biopesticides, biostimulants, and biofertilizers, sharing a biological-crop-protection orientation with Ascribe's small-molecule biofungicide platform.

TypeEmerging player
Description

Symborg develops and commercializes biostimulants and biological crop protection products, including products positioned as alternatives to chemical fungicides, overlapping with Ascribe's biopesticide/biostimulant positioning.

TypeDirect peer
Description

Bioceres is a Latin American ag biologicals platform that commercializes biofungicides, biostimulants, and inoculants across row crops, overlapping with Ascribe's Brazil-first regulatory and commercial strategy.

TypeEmerging player
Description

Ginkgo Bioworks operates a synthetic biology platform that develops engineered microbes and bioproducts for agriculture, comparable to Ascribe in using a deep biotech platform to generate novel crop-protection active ingredients.

TypeDirect peer
Description

Marrone Bio is a biopesticide company (now part of Bioceres) that develops and commercializes biological crop protection products, including biofungicides, making it a direct competitor in the same product category Ascribe targets with Phytalix.

TypeBroad incumbent
Description

Novonesis (the merged Novozymes and Chr. Hansen BioAg) is a large incumbent in agricultural biologicals including biopesticides and biostimulants, representing the kind of scaled competitor Ascribe is positioning against in the biofungicide market.

8Certis Biologicals
TypeDirect peer
Description

Certis Biologicals is a dedicated biopesticide manufacturer (subsidiary of Mitsui & Co.) offering biofungicides, bioinsecticides, and bionematicides, and is one of the closest direct peers to Ascribe in the biofungicide and biological crop protection category.

TypeEmerging player
Description

Pivot Bio is a U.S. ag biologicals company that uses microbial science to replace synthetic nitrogen fertilizer; it competes for the same row-crop biologicals customer wallet as Ascribe even though it addresses a different agronomic input.

TypeEmerging player
Description

Indigo Ag develops and commercializes microbial seed treatments and biostimulants for row crops, comparable to Ascribe's extension of Phytalix into seed treatment applications with Corteva.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds8 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors12 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Ascribe Bioscience

Crop Protection Biofungicidesascribebio.com

Ascribe Bioscience is a Cornell-spinout agricultural biotech that develops Phytalix®, a natural small-molecule biofungicide based on soil-microbiome signaling molecules (ascarosides) that prime plant immunity, sold to commodity and specialty growers via channel partners Nutrien/Loveland, Corteva, and Syngenta.

What Ascribe Bioscience does

Ascribe Bioscience is a private agricultural biotechnology company founded in 2017 and headquartered in Ithaca, New York. It was spun out of the Boyce Thompson Institute at Cornell University and develops crop protection products based on ascarosides — small signaling molecules naturally produced by soil microbiome organisms that prime plants' innate immune systems against fungal, bacterial, and viral pathogens.

The company's flagship product, Phytalix®, is a natural small-molecule biofungicide positioned as a new category of crop protection. Unlike conventional fungicides that act through toxicity, Phytalix strengthens plant defenses and is non-toxic, biodegradable, non-GMO, and bee-friendly. The product is effective at milligram-per-acre concentrations, can be applied as a foliar spray, seed treatment, or tank mix with other inputs, and is claimed to enable growers to cut synthetic fungicide use by 50% or more while maintaining yields. The platform is backed by a decade of research and more than 500 field trials worldwide.

Ascribe operates a B2B, channel-driven go-to-market rather than selling direct to growers. Distribution is anchored by Loveland Products (a Nutrien division) for U.S. row crops, Corteva for seed-treatment applications, and Syngenta under an exclusive arrangement for Southeast Asia (with planned 2029 launch). Initial regulatory approval is being pursued in Brazil, followed by the U.S. and other markets. The company serves large-scale commodity growers (wheat, soy, potatoes, row crops) as the primary segment, with specialty crop producers as a secondary segment. As of late 2025 it has raised approximately $14.5M in disclosed funding across seed and Series A rounds from investors including Corteva Catalyst, Acre Venture Partners, Syngenta Group Ventures, and ICIG Ventures.

Ascribe Bioscience firmographics

Firmographics
Name
Ascribe Bioscience
Legal name
Ascribe Bioscience Inc.
Website
https://ascribebio.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
11–50 employees
Short description
Ascribe Bioscience is a Cornell-spinout agricultural biotech that develops Phytalix®, a natural small-molecule biofungicide based on soil-microbiome signaling molecules (ascarosides) that prime plant immunity, sold to commodity and specialty growers via channel partners Nutrien/Loveland, Corteva, and Syngenta.
Ownership category
akta.pro rank

Ascribe Bioscience industry classification

Industry
Product category
Crop Protection Biofungicides
NAICS
Pesticide and Other Agricultural Chemical Manufacturing (32532), Pesticide, Fertilizer, and Other Agricultural Chemical Manufacturing (3253)
SIC
Agricultural Chemicals (2870)
akta.pro industry
PRIMARYAFABAEAL
Biological Seed Treatments & Inoculants (within Biologicals)
Agriculture & Food Production/Agricultural Inputs & Agrochemicals/Biologicals & Biopesticides (Microbials, Botanicals, Beneficial Insects)
SECONDARYAFABAAAC
Fungicides
Agriculture & Food Production/Agricultural Inputs & Agrochemicals/Crop Protection Chemicals (Herbicides, Insecticides, Fungicides)
SECONDARYAFABAKAJ
Soil Health Activators & Biostimulants (Humates, Amino Acids, Seaweed Extracts)
Agriculture & Food Production/Agricultural Inputs & Agrochemicals/Organic & Regenerative Inputs (OMRI Inputs, Compost, Natural Pest Control)
SECONDARYAFABAFAJ
Seed Inoculants & Biological Seed Enhancers (Rhizobia, Mycorrhizae, PGPR)
Agriculture & Food Production/Agricultural Inputs & Agrochemicals/Seed & Planting Inputs (Seeds, Seed Treatments, Inoculants)

Keywords

  • Biological crop protection
  • Natural biofungicides
  • Plant disease management
  • Agricultural biotechnology
  • Soil microbiome solutions

Where Ascribe Bioscience is headquartered

Location

Headquarters

HQ city
Ithaca
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Ascribe Bioscience business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain

Revenue model

  1. Phytalix Biofungicide Sales: Revenue generated from sale of Phytalix, a natural crop protection product. The product is sold to farmers and agricultural producers for crop disease control and plant health benefits. Applied as foliar spray or seed treatment.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Ascribe Bioscience product offering

Product offering

Core offering

Ascribe Bioscience develops and commercializes Phytalix®, a natural small-molecule biofungicide that uses ascaroside signaling molecules from the soil microbiome to prime plants' innate defense systems against fungal, bacterial, and viral pathogens. The product is sold to farmers and agricultural producers as a foliar spray, seed treatment, or tank mix, and is positioned to reduce synthetic fungicide use by 50% or more while maintaining yields. Distribution is delivered through agricultural input channel partners (Loveland Products/Nutrien, Syngenta) and direct enterprise sales across the U.S., Brazil, and Southeast Asia.

Product overview

Ascribe Bioscience develops natural crop protection solutions based on small molecules (ascarosides) from the soil microbiome. The company's portfolio centers on Phytalix®, a single flagship natural small-molecule biofungicide that can be applied as foliar spray or seed treatment. Phytalix® strengthens plants' innate immune systems rather than relying on toxic effects to kill pathogens, offering broad-spectrum protection against fungal, bacterial, and viral diseases while being environmentally friendly, non-toxic, and bee-friendly. The product enables growers to reduce synthetic fungicide applications by 50% or more while maintaining yields.

Differentiator

Problem solved

Functional benefit

Brands

  • Phytalix: Natural small-molecule biofungicide that provides broad-spectrum protection against fungal, bacterial, and viral diseases. Non-toxic, biodegradable, and can be applied as seed treatment or foliar spray.

Products and services

  • Phytalix® Biofungicide A natural small-molecule biofungicide that primes plants' innate defense systems against fungal, bacterial, and viral diseases. Applied as foliar spray, seed treatment, or tank mix; non-toxic, biodegradable, non-GMO, and bee-friendly. Designed for farmers and agricultural producers seeking to reduce synthetic fungicide use by 50% or more while maintaining yields.
  • Phytalix® Seed Treatment Application A seed treatment variant/extension of the Phytalix® biofungicide platform developed in collaboration with Corteva, allowing growers to apply Phytalix® directly to seeds to protect against soil- and seedling-stage pathogens, broadening use cases beyond foliar application.
  • Phytalix® for Asian Markets (Southeast Asia) Geographic/market variant of the Phytalix® biofungicide being commercialized through Syngenta with exclusive rights in Southeast Asia for Asian farmers, targeting regional fungal and other crop pathogens with the same natural small-molecule mode of action.

Quantifiable outcome

  • Reduces synthetic fungicide applications by 50% or more while maintaining yields
  • +2 more outcomes

Companies that use Ascribe Bioscience

Customer profile

Segments2 records

Ideal customer profiles3 records

Ascribe Bioscience technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Ascribe Bioscience partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered flagship and major.

  • SyngentaflagshipChannel Partner/ Reseller/ Distributor · 4 June 2026Strategic partnership to develop and commercialize PHYTALIX® for Asian farmers. Syngenta receives exclusive rights for Southeast Asia with plans for market launch in 2029, following extensive validation and trials.
  • CortevamajorStrategic or Co-development Partner · 11 March 2026Collaboration announced to advance seed treatment use for Phytalix® biofungicide, expanding the product's application method beyond foliar sprays.
  • Loveland Products / NutrienmajorStrategic or Co-development PartnerCollaboration with Loveland Products, a division of Nutrien, to launch Phytalix-based solutions for U.S. row crops. The partnership has expanded over time, indicating ongoing commercial collaboration.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Ascribe Bioscience competitors and assessment

Company assessment

Direct peers

  • AgBiome: AgBiome is a U.S.-based agricultural biologicals company that discovers and develops microbial biopesticides and biostimulants for crop protection, directly comparable to Ascribe's natural, microbiome-derived biofungicide strategy and row-crop focus.
  • Bioceres Crop Solutions: Bioceres is a Latin American ag biologicals platform that commercializes biofungicides, biostimulants, and inoculants across row crops, overlapping with Ascribe's Brazil-first regulatory and commercial strategy.
  • Marrone Bio Innovations (Bioceres Crop Solutions): Marrone Bio is a biopesticide company (now part of Bioceres) that develops and commercializes biological crop protection products, including biofungicides, making it a direct competitor in the same product category Ascribe targets with Phytalix.
  • Certis Biologicals: Certis Biologicals is a dedicated biopesticide manufacturer (subsidiary of Mitsui & Co.) offering biofungicides, bioinsecticides, and bionematicides, and is one of the closest direct peers to Ascribe in the biofungicide and biological crop protection category.

Emerging players

  • BioConsortia: BioConsortia is a U.S. ag biotech company that uses microbial consortia to develop biopesticides, biostimulants, and biofertilizers, sharing a biological-crop-protection orientation with Ascribe's small-molecule biofungicide platform.
  • Symborg: Symborg develops and commercializes biostimulants and biological crop protection products, including products positioned as alternatives to chemical fungicides, overlapping with Ascribe's biopesticide/biostimulant positioning.
  • Ginkgo Bioworks: Ginkgo Bioworks operates a synthetic biology platform that develops engineered microbes and bioproducts for agriculture, comparable to Ascribe in using a deep biotech platform to generate novel crop-protection active ingredients.
  • Pivot Bio: Pivot Bio is a U.S. ag biologicals company that uses microbial science to replace synthetic nitrogen fertilizer; it competes for the same row-crop biologicals customer wallet as Ascribe even though it addresses a different agronomic input.
  • Indigo Ag: Indigo Ag develops and commercializes microbial seed treatments and biostimulants for row crops, comparable to Ascribe's extension of Phytalix into seed treatment applications with Corteva.

Broad incumbents

  • Novonesis (Novozymes BioAg): Novonesis (the merged Novozymes and Chr. Hansen BioAg) is a large incumbent in agricultural biologicals including biopesticides and biostimulants, representing the kind of scaled competitor Ascribe is positioning against in the biofungicide market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Ascribe Bioscience social profiles

Digital presence

Ascribe Bioscience financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Ascribe Bioscience leadership team

Management profile

Number of profiles

Profiles2 records

Ascribe Bioscience funding detail

Funding detail

Funding overview

Funding rounds8 records

Investors12 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Ascribe Bioscience M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ascribe Bioscience

What does Ascribe Bioscience do?

Ascribe Bioscience develops and commercializes Phytalix®, a natural small-molecule biofungicide that uses ascaroside signaling molecules from the soil microbiome to prime plants' innate defense systems against fungal, bacterial, and viral pathogens. The product is sold to farmers and agricultural producers as a foliar spray, seed treatment, or tank mix, and is positioned to reduce synthetic fungicide use by 50% or more while maintaining yields. Distribution is delivered through agricultural input channel partners (Loveland Products/Nutrien, Syngenta) and direct enterprise sales across the U.S., Brazil, and Southeast Asia.

Is Ascribe Bioscience a public or private company?

Ascribe Bioscience is a private company. It is classified as venture growth investor backed and is currently operating.

When was Ascribe Bioscience founded?

Ascribe Bioscience was founded in 2017. It employs 11 to 50 people.

Where is Ascribe Bioscience based?

Ascribe Bioscience is headquartered in Ithaca, United States, in the North America region.

How does Ascribe Bioscience make money?

One revenue line is on record: phytalix Biofungicide Sales.

Who are Ascribe Bioscience's main competitors?

Direct peers on record are AgBiome, Bioceres Crop Solutions, Marrone Bio Innovations (Bioceres Crop Solutions) and Certis Biologicals. Emerging players are BioConsortia, Symborg, Ginkgo Bioworks, Pivot Bio and Indigo Ag. Novonesis (Novozymes BioAg) is listed as a broad incumbent.

Does Ascribe Bioscience have an API?

No public API is recorded for Ascribe Bioscience.

What industry is Ascribe Bioscience in?

Ascribe Bioscience's product category is Crop Protection Biofungicides. Its primary akta.pro industry code is AFABAEAL, Biological Seed Treatments & Inoculants (within Biologicals), with a secondary code of AFABAAAC, Fungicides. Its NAICS code is 32532 and its SIC code is 2870.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business Wire BlogSyngenta and Ascribe Bioscience Partner to Bring New Biofungicide to Asian FarmersSyngenta and Ascribe Bioscience have formed a partnership to develop and commercialize PHYTALIX®, a biofungicide designed to enhance crop resistance against diseases in Asian farmers. The agreement includes exclusive rights for Syngenta in Southeast Asia, with plans for market launch in 2029, following extensive validation and trials.Pulse 2.0Ascribe Bio: $12 Million Series A Raised For Launching Next-Generation Natural BiofungicideAscribe Bio, a biotechnology company based in Ithaca, New York, has closed an oversubscribed $12 million Series A financing round co-led by Corteva (through its Corteva Catalyst platform) and Acre Venture Partners, with participation from Syngenta Group Ventures, Trailhead Capital, Silver Blue, Cultivation Capital, and The Yield Lab. The funding will support the global launch of Phytalix, Ascribe's breakthrough broad-spectrum biofungicide, and advance its small-molecule technology platform for sustainable crop protection. The company expects its first regulatory approval later this year in Brazil, followed by launches in the United States and other key agricultural markets.YahooAscribe Bio Closes $12 Million Series A Financing to Advance Next-Generation Natural Crop Protection Co-Led by Acre Venture Partners and CortevaAscribe Bio closed a $12 million Series A financing co-led by Corteva and Acre Venture Partners. The funds support the commercial launch of Phytalix, a biofungicide, with first regulatory approval expected later this year in Brazil. USA and other markets will follow.Venture Capital Access OnlineAscribe Bio Closes $12 Million Series A Financing to Advance Next-Generation Natural Crop Protection Co-Led by Acre Venture Partners and CortevaAscribe Bio, an Ithaca-based agricultural technology company, announced the closing of a $12 million Series A financing round co-led by Corteva (through its Corteva Catalyst platform) and Acre Venture Partners, with participation from Syngenta Group Ventures, Trailhead Capital, Silver Blue LLC, Cultivation Capital, and The Yield Lab. The funding will advance Ascribe's Phytalix® biofungicide, a broad-spectrum natural crop protection product, supporting manufacturing scale-up and early commercialization activities. The company expects Phytalix's first regulatory approval later this year in Brazil, with the USA and other markets to follow.No-tillfarmerLoveland Products, Ascribe Bioscience Expand Collaboration on Phytalix-Based SolutionsLoveland Products and Ascribe Bioscience have expanded their collaboration in the U.S. market to include additional proprietary Phytalix premixes, building on a partnership established in 2023. This strategic initiative aims to strengthen Loveland's biological platform with products derived from soil microbiome molecules that offer broad-spectrum disease control and improved plant health. Product submissions to the EPA are anticipated by the end of 2025.ForbesNew Biopesticide Is A Breakthrough For Global Food SecurityAscribe Bio's Phytalix biopesticide reduced bacterial leaf blight severity by 83% and boosted rice yields by up to 30% in field trials. The product, derived from soil microbiome molecules, targets the disease that can cut yields by 80% in India. Pending regulatory approvals in Brazil and the U.S. could expand its market.NewswireSource Agriculture Corp. Makes Strategic Investment in Ascribe Bioscience to Advance Sustainable Crop Protection SolutionsSource Agriculture Corp. announced a strategic investment in Ascribe Bioscience, a company developing sustainable crop protection from soil microbiome. Ascribe's lead product, Phytalix, primes plant immune systems against pathogens and is non-toxic and biodegradable. The investment aims to advance natural, effective crop protection solutions.PR NewswireSource Agriculture Corp. Makes Strategic Investment in Ascribe Bioscience to Advance Sustainable Crop Protection SolutionsSource Agriculture Corp. announced a strategic investment in Ascribe Bioscience, a company developing sustainable crop protection from soil microbiome. Ascribe's lead product, Phytalix, primes plant immune systems against pathogens and is non-toxic, biodegradable, and non-GMO. The investment aims to advance natural alternatives to chemical pesticides.